Qternmet XR approved in US for treatment of type-2 diabetes

This article was originally published here

The approval is based on two Phase III trials, which evaluated combinations of dapagliflozin and saxagliptin on a background of metformin over 24 weeks, in patients with inadequately-controlled

The post Qternmet XR approved in US for treatment of type-2 diabetes appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply